Merger Announced

Werewolf Therapeutics and Ambros Therapeutics merger

US$500m equity value

Announced 21 Aug 2026

Advisers

Ambros Therapeutics

Target

Legal adviser

Werewolf Therapeutics

Acquirer

Financial adviser
Legal adviser
Target
Ambros Therapeutics
Acquirer
Werewolf Therapeutics
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development, Rare Disease

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.